Molbio Diagnostics Shares Debut at 21% Premium Over IPO Price on BSE and NSE Molbio Diagnostics shares made a strong debut on the stock exchanges, listing at a 21% premium over their initial public offering (IPO) price on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). The stock opened at Rs 980 per share on both exchanges, marking a 21.44% increase from the IPO price of Rs 807. This performance exceeded grey market expectations, which had anticipated a listing premium of around 15%. The Rs 939.70 crore IPO was priced at Rs 807 per share, comprising a fresh issue of 25 lakh shares valued at Rs 200 crore and an offer for sale (OFS) of 92 lakh shares worth Rs 739.70 crore. Kotak Mahindra Capital Company served as the book-running lead manager, while KFin Technologies Ltd. acted as the registrar. The company plans to utilize the IPO proceeds to expand its infrastructure and enhance its research and manufacturing capabilities. A significant portion of the funds, approximately Rs 125.12 crore, is allocated for capital expenditure, including the development of a research and development facility, a Centre of Excellence, and related office infrastructure. Another Rs 80.81 crore is earmarked for plant, machinery, and equipment upgrades at its manufacturing facilities in Goa and Visakhapatnam. The remaining proceeds will be used for general corporate purposes, with an estimated total utilization of Rs 205.93 crore from the IPO. Established in October 2000, Molbio Diagnostics Ltd. is a global molecular diagnostics company specializing in the development, manufacturing, and commercialization of rapid diagnostic solutions for infectious and non-communicable diseases.#national_stock_exchange #bombay_stock_exchange #kfin_technologies_ltd #molbio_diagnostics #kotak_mahindra_capital_company
MV Electrosystems IPO Opens Today: GMP Signals 23% Listing Premium MV Electrosystems is set to launch its initial public offering (IPO) today, aiming to raise nearly Rs 300 crore from the primary market. The company, which specializes in providing solutions for railway rolling stock, has seen its shares command a grey market premium (GMP) of over 23% ahead of the listing. According to recent trends, the GMP for the IPO is estimated at Rs 100, suggesting a potential listing gain of approximately 23.5% over the upper end of the price band. However, it is important to note that grey market premiums are unofficial and subject to rapid changes before the stock officially lists. The IPO, a book build issue of Rs 290 crore, involves a fresh issue of 68.23 lakh shares. The price band for the offering has been set between Rs 400 and Rs 425 per share. Retail investors are required to bid for a single lot size of 34 shares, which amounts to an investment of Rs 14,450. Small Non-Institutional Investors (S-HNIs) must bid for 14 lots, requiring Rs 2,02,300, while Big Non-Institutional Investors (B-HNIs) need to bid for a minimum of 70 lots, equivalent to Rs 10,11,500. Qualified Institutional Buyers (QIBs) will be allocated not less than 75% of the net issue, while retail investors will receive no more than 10% of the net issue. Non-Institutional Investors (NIIs) will be allocated up to 15% of the shares. Sundae Capital Advisors Ltd. serves as the book running lead manager for the IPO, and KFin Technologies Ltd. is designated as the registrar. The IPO’s allotment is scheduled for August 4, with demat credits expected on August 5.#mv_electrosystems #gmp #sundae_capital_advisors_ltd #kfin_technologies_ltd #railway_rolling_stock
